• Biopsy, Gallbladder (Cholecystectomy)
  • Magnesium/Creatinine Ratio, Random, Urine
  • B and T Cell Gene Rearrangement, Blood
  • TNNC1 (Troponin C) Gene Mutation Analysis
  • Electrophoresis, Protein, CSF
  • SARS-CoV-2 (Coronavirus), Antigen Test
  • Praxis™ Extended RAS Panel
  • Lysergic Acid Diethylamide, Urine
  • Optical Genome Mapping for copy number alterations, aneuploidy, and balanced/complex structural rearrangements in Hematological Malignancies
  • Transforming Growth Factor Beta (TGFβ)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /UBE3A Gene Mutation Analysis, Angelman Syndrome, Tissue
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

UBE3A Gene Mutation Analysis, Angelman Syndrome, Tissue
Medical Test

Methodology
Access to UBE3A Gene Mutation Analysis, Angelman Syndrome, Tissue is restricted.